It can influence the expression of pro-inflammatory cytokines, activate TLR2/PPARγ receptors, and disrupt the balance between HIF-1α and HIF-2α, which is associated with impaired systemic metabolism, inflammation, and muscle catabolism in patients with chronic heart failure (CHF) [3,4]. The gene discussed is EPAS1; the disease is congestive heart failure.